Issue 7, 2011

Synthesis and biological evaluation of novel 1-aryl, 5-(phenoxy-substituted)aryl-1,4-pentadien-3-one derivatives

Abstract

A series of 1-aryl, 5-(phenoxy-substituted)aryl-1,4-pentadien-3-one derivatives were synthesized and evaluated for anticancer activity. Amongst the synthesized ethers, 4A and 4Y exhibited substantial antiproliferative activity with IC50 values ranging from 6.6–8.6 μmol L−1 against a variety of human cancer cell lines. Preliminarily mechanism of antitumor action of 4A by DNA Ladder, Annexin V/PI double staining and related studies indicated growth inhibition of PC3, BGC-823 and Bcap-37 cells by induction of tumor cells apoptosis.

Graphical abstract: Synthesis and biological evaluation of novel 1-aryl, 5-(phenoxy-substituted)aryl-1,4-pentadien-3-one derivatives

Supplementary files

Article information

Article type
Concise Article
Submitted
07 Feb 2011
Accepted
25 Mar 2011
First published
14 Apr 2011

Med. Chem. Commun., 2011,2, 585-589

Synthesis and biological evaluation of novel 1-aryl, 5-(phenoxy-substituted)aryl-1,4-pentadien-3-one derivatives

K. Yuan, B. Song, L. Jin, S. Xu, D. Hu, X. Xu and S. Yang, Med. Chem. Commun., 2011, 2, 585 DOI: 10.1039/C1MD00038A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements